Is Applied Genetic Technologies Corporation (AGTC) a Buy, Sell, or Hold?
NASDAQ : AGTC
Applied Genetic Technologies Corporation
$0.3936 USD
$0 (0.0%)
- Volume
- 764.53K
- Average Volume
- 1.28M
- Market Capitalization
- $0
- P/E Ratio
- -0.25
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.83
- Year Low
- $0.23
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.97
Company Overview
NASDAQ
Susan Washer
Biotechnology
Healthcare
AGTC
102
US
USD
Liquidity Metrics
0.76
1.97
1.97
1.84
0.00
Sales & Valuation
$325K
0.00
0.60
0.00
-1.50
Profitability
-$1.59
-$71.42M
-21976.62%
-21153.85%
-123.91%
-107.11%
P/E Metrics
-0.25
-0.01
-0.01
Analyst Price Target & Rating
0/5
14 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
-$23.9M
-73.52
0.37
1.97
-123.91%
-127.33%
-402.97%
%
0 days
Company Executives
| Name | Title |
|---|---|
| Nicholas Muzyczka | Co-Founder |
| Richard Jude Samulski | Co-Founder |
| William W. Hauswirth | Co-Founder & Member of Ophthalmology Scientific Advisory Board |
| Susan Washer | Pres, Chief Executive Officer & Director |
| Gerald Anthony Reynolds | Chief Accounting Officer, Principal Accounting Officer & Treasurer |
| Terence R. Flotte | Co-Founder |
| Susan Schneider | Chief Medical Officer |
| Jonathan I. Lieber | Chief Financial Officer |
| Barry J. Byrne | Co-Founder |
| Abraham Scaria | Chief Scientific Officer |
Poll Results
No votes yet today — be the first to share your view!
About Applied Genetic Technologies Corporation (NASDAQ:AGTC) Stock
Applied Genetic Technologies Corporation (AGTC) is a clinical-stage biotechnology company focused on developing innovative genetic therapies aimed at transforming the lives of patients battling rare and debilitating diseases. Its advanced product portfolio includes three ophthalmology development programs addressing two specific targets. These encompass treatments for X-linked retinitis pigmentosa and achromatopsia, both currently undergoing Phase 1/2 clinical trials. Additionally, an optogenetic therapy candidate is in development to tackle advanced retinal conditions. Beyond its ophthalmic initiatives, AGTC is advancing several preclinical programs. These early-stage endeavors include a program for otology (ear disorders), another for dry age-related macular degeneration, and two targeti ... ng central nervous system disorders like frontotemporal dementia and amyotrophic lateral sclerosis. The company maintains strategic partnerships with entities such as the University of Florida, Bionic Sight, Inc., and Otonomy, Inc. Founded in 1999, AGTC's operations are based out of its headquarters in Alachua, Florida.
Frequently Asked Questions
-
What is the current Applied Genetic Technologies Corporation (AGTC) stock price?
-
Applied Genetic Technologies Corporation(NASDAQ:AGTC) stock price is $0.3936 in the last trading session. During the trading session, AGTC stock reached the peak price of $2.825 while $0.2303 was the lowest point it dropped to. The percentage change in AGTC stock occurred in the recent session was 0.0% while the dollar amount for the price change in AGTC stock was $0.
-
AGTC's industry and sector of operation?
-
The NASDAQ listed AGTC is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of AGTC?
-
Nicholas Muzyczka | Co-Founder
Richard Jude Samulski | Co-Founder
William W. Hauswirth | Co-Founder & Member of Ophthalmology Scientific Advisory Board
Susan Washer | Pres, Chief Executive Officer & Director
Gerald Anthony Reynolds | Chief Accounting Officer, Principal Accounting Officer & Treasurer -
How many employees does AGTC have?
-
Number of AGTC employees currently stands at 102. AGTC operates from 14193 Nw 119Th Terrace, Suite #10, Alachua, FL 32615, US.
-
Link for AGTC official website?
-
Official Website of AGTC is: https://agtc.com
-
How do I contact AGTC?
-
AGTC could be contacted at phone #13864622204 and can also be accessed through its website. AGTC operates from 14193 Nw 119Th Terrace, Suite #10, Alachua, FL 32615, US.
-
How many shares of AGTC are traded daily?
-
The average number of AGTC shares traded daily for last 3 months was 1.28M.
-
What is the market cap of AGTC currently?
-
The market value of AGTC currently stands at $0 with its latest stock price at $0.3936